Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin for Plantar Fasciitis
NCT01678001Phase 4Completed
- Sponsor
- Rothman Orthopaedics
- Start
- Aug 2012
- Primary completion
- Aug 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in plantar fasciitis, sponsored by Rothman Orthopaedics. Started Aug 2012; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
plantar fasciitis
Beyond the preview
Go deeper on NCT01678001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01678001.